Henrik S.
- Country
- Denmark
- Department
- Danish Headache Center, Department of Neurology
Research Overview
- Efficacy of Eptinezumab as Adjunctive Therapy in Preventing Migraine and Treating Medication Overuse Headache in Patients with Dual Diagnosis
- Efficacy and Safety of Botulinum Toxin A in Persistent Post-Traumatic Headache: A Double-Blind, Randomized, Placebo-Controlled Trial
- Evaluation of Botulinum Toxin Type A Efficacy and Safety in Trigeminal Neuralgia: A Double-Blind, Randomized, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 53 of 106 partner sites.
Specializations
Headache Disorders
This investigator specializes in the treatment of complex post-traumatic headache conditions, with particular focus on innovative therapeutic approaches using botulinum toxin A. Their research encompasses the evaluation of neuro-inflammatory biomarkers and their role in treatment efficacy.
- Post-traumatic headache management
- Neuro-inflammatory biomarker analysis
- Advanced therapeutic interventions
Migraine Treatment
The investigator conducts research in chronic migraine and medication overuse headache, exploring novel therapeutic options including eptinezumab. Their work focuses on preventive treatments and management strategies for complex migraine cases.
- Chronic migraine prevention
- Medication overuse management
- Preventive therapy development
Neurological Pain Management
Research expertise extends to trigeminal neuralgia treatment, investigating therapeutic applications of botulinum toxin A for neurological pain conditions. The investigator focuses on developing effective treatment protocols for facial pain disorders.
- Trigeminal neuralgia treatment
- Facial pain management
- Neurotoxin therapy applications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.